KfW Research’s latest study reveals that Germany is facing increased competition from China in EU export markets. While Germany still maintains ...

The biggest M&A activity of the year arrived in the form of Merck KGaA’s earlier-disclosed agreement to buy Springworks Therapeutics Inc. for $47 per share in cash, which represents an equity value of ...